Skip to content

Healthy Growth Strategy 2022–2025

Raisio’s main goal during the strategy period is to grow based on the new capabilities, increased capacity and new product categories.

Raisio’s Healthy Growth Strategy is based on three focus areas

Benecol® and plant stanol ester solutions

Raisio continues to invest in growing the international Benecol® brand. Plant stanol ester in Benecol® products has been shown to lower cholesterol and the health claim has been approved by the EU commission. Furthermore, Raisio invests also in a research program to study other potential health beneficial properties of plant stanol ester.

Benecol® and plant stanol ester solutions are key contributors to Raisio’s profitability. Our goal is to increase the net sales from these products by an average of 4 per cent annually (CAGR) in 2020‒2025.

Value added oats and ingredients

Raisio continues to expand internationally in the B2B as well as the consumer market based on the company’s strong expertise in oats. Our goal is to grow the net sales from these products faster than the market, i.e., by an average of 21 per cent annually (CAGR) in 2020‒2025.

Plant proteins

Consumer choices are increasingly directed towards healthy and sustainably produced, plant-based food. Raisio wants to strengthen its position in this promising and fast-growing market in Finland as well as internationally. Our goal is to increase the net sales from these products by an average of 35 per cent annually (CAGR) in 2021─2025.


Raisio's strategic focus areas

Food for Health, Heart and Earth.

Megatrends support our strategy

Health is understood as holistic wellbeing. Awareness of the importance of mental health has increased.

As plant-based eating becomes more mainstream and there is more variety to choose from, more is expected from product quality.

Sustainable choices gain importance. Consumers are looking for concrete actions they can understand and afford.​

Raisio’s Financial Targets ​2022−2025*


Our target is to grow the combined net sales from the three strategic focus areas by an average of 11% annually and the net sales of the entire Group by 9% annually during the strategy period 2022‒2025.


We are targeting a comparable EBIT of over 13 per cent of the Group’s net sales in 2025. The commissioning and commercialisation stage of the new production facility and growth investments in Verso Food, acquired in spring 2021, put pressure on Raisio’s profitability during the first years of the strategy period.

*The targets have been defined for Raisio’s current company structure on June 10th 2021 and do not include potential business acquisitions.​